PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV

Henry Meds Online GLP-1 Weight Management, TRT & More

2:45Nov 2024

Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

The presenter says the service is available in over 44 states in the US and uses licensed healthcare professionals for consultations and prescriptions. The treatments listed cover overweight and obesity, low testosterone and insomnia.

Published by General Consumer on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

The presenter says the weight loss range is the strongest part of the offering, with the most variety and the best deals, including popular brand name drugs. He then describes one GLP-1 receptor agonist, which the auto captions render as "sagy" or "magati". He explains that GLP-1 is a hormone the body makes to help control blood sugar and appetite, and that the medication mimics it by slowing digestion, so a person feels full longer and has fewer cravings.

The presenter says the insomnia treatments are three oral medications, also sold as generics, and that they can help sleep quality. He describes the testosterone therapy options as more limited than the other two areas. He says the company stands out for its focus on safety, with a thorough checkup before any medication is prescribed.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:30 He says the service treats overweight and obesity, low testosterone and insomnia, with weight loss drugs offering the most variety and best deals.
  2. 1:02 He explains that the GLP-1 medication he describes mimics a hormone that helps control blood sugar and appetite, and that it can be taken orally or as an injectable.
  3. 1:32 He says the insomnia treatments are three oral medications also sold as generics, and that the testosterone offerings are more limited.

Key moments

Tap one to play from there.

  1. 0:00 <Untitled Chapter 1>
  2. 0:05 Intro
  3. 0:11 Discount Link
  4. 0:59 Semaglutide For Weight loss
  5. 1:28 Insomnia treatment
  6. 2:08 Pricing
  7. 2:23 Is it Worth it?

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • What is GLP-1? The hormone, how the drugs work, and every GLP-1 medication on the market

    GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after you eat. It tells the pancreas to release insulin when blood sugar is high, holds back glucagon, slows how fast the stomach empties, and acts on the parts of the brain that regulate appetite. GLP-1 drugs copy that hormone but last far longer: a week for the injections, a day for the pills. Seven brands are on the US market, from Ozempic and Mounjaro for type 2 diabetes to Wegovy, Zepbound and Foundayo for weight loss.

  • GLP-1 vs GLP-2 vs GLP-3: what the names mean, and which ones you can actually buy

    GLP-1 drugs such as semaglutide act on one receptor. "GLP-2" is used online for tirzepatide (Zepbound, Mounjaro), which acts on two, GIP and GLP-1, and "GLP-3" for retatrutide, which adds the glucagon receptor. Neither nickname is the real name: GLP-2 is a separate gut hormone whose drug, Gattex, treats short bowel syndrome. Retatrutide produced 28.3% mean weight loss at 80 weeks in its phase 3 trial but is not FDA-approved; Lilly plans to file in Q1 2027. Tirzepatide is the strongest option you can buy today.

  • GLP-1s for binge eating: what semaglutide, liraglutide and tirzepatide trials show

    No GLP-1 is FDA approved for binge eating disorder; the only approved drug is lisdexamfetamine (Vyvanse). A 2026 meta-analysis of 25 randomized trials reports moderate drops in binge eating on GLP-1s, larger in people diagnosed with the disorder, but rates every trial at high risk or some concerns of bias. The one placebo-controlled liraglutide trial in diagnosed BED showed no significant difference. A tirzepatide versus Vyvanse trial is recruiting.

Next steps

GLP-1 prices

Find more like it

Food noise and cravingsCost and insuranceHow it works

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV